130 related articles for article (PubMed ID: 8880898)
1. Interaction of BW A868C, a prostanoid DP-receptor antagonist, with two receptor subtypes in the rabbit isolated saphenous vein.
Lydford SJ; McKechnie KC; Leff P
Prostaglandins; 1996 Aug; 52(2):125-39. PubMed ID: 8880898
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological studies on prostanoid receptors in the rabbit isolated saphenous vein: a comparison with the rabbit isolated ear artery.
Lydford SJ; McKechnie KC; Dougall IG
Br J Pharmacol; 1996 Jan; 117(1):13-20. PubMed ID: 8825337
[TBL] [Abstract][Full Text] [Related]
3. Piglet saphenous vein contains multiple relaxatory prostanoid receptors: evidence for EP4, EP2, DP and IP receptor subtypes.
Wilson RJ; Giles H
Br J Pharmacol; 2005 Feb; 144(3):405-15. PubMed ID: 15655509
[TBL] [Abstract][Full Text] [Related]
4. The classification of prostaglandin DP-receptors in platelets and vasculature using BW A868C, a novel, selective and potent competitive antagonist.
Giles H; Leff P; Bolofo ML; Kelly MG; Robertson AD
Br J Pharmacol; 1989 Feb; 96(2):291-300. PubMed ID: 2924081
[TBL] [Abstract][Full Text] [Related]
5. Effects of BW A868C, a selective prostaglandin DP receptor antagonist, in dog isolated vascular preparations.
Liu YJ; Jackson DM; Blackham A
Eur J Pharmacol; 1996 May; 303(3):187-92. PubMed ID: 8813566
[TBL] [Abstract][Full Text] [Related]
6. Antagonism of PGD2 vasodepressor responses in the rat in vivo by the novel, selective antagonist, BW A868C.
Hamid-Bloomfield S; Whittle BJ
Br J Pharmacol; 1989 Feb; 96(2):307-12. PubMed ID: 2647205
[TBL] [Abstract][Full Text] [Related]
7. The antagonism by BW A868C of PGD2 and BW245C activation of human platelet adenylate cyclase.
Trist DG; Collins BA; Wood J; Kelly MG; Robertson AD
Br J Pharmacol; 1989 Feb; 96(2):301-6. PubMed ID: 2466517
[TBL] [Abstract][Full Text] [Related]
8. Partial agonist effects of BW A868C, a selective DP receptor antagonist, on Cl- secretion in dog tracheal epithelium.
Liu YJ; Jackson DM; Blackham A; Leff P
Eur J Pharmacol; 1996 May; 304(1-3):117-22. PubMed ID: 8813592
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory prostanoid EP receptors in human non-pregnant myometrium.
Hillock CJ; Crankshaw DJ
Eur J Pharmacol; 1999 Jul; 378(1):99-108. PubMed ID: 10478569
[TBL] [Abstract][Full Text] [Related]
10. A novel inhibitory prostanoid receptor in piglet saphenous vein.
Coleman RA; Grix SP; Head SA; Louttit JB; Mallett A; Sheldrick RL
Prostaglandins; 1994 Feb; 47(2):151-68. PubMed ID: 8016385
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the prostaglandin E2 sensitive (EP)-receptor in the rat isolated trachea.
Lydford SJ; McKechnie K
Br J Pharmacol; 1994 May; 112(1):133-6. PubMed ID: 8032634
[TBL] [Abstract][Full Text] [Related]
12. Further studies on ocular responses to DP receptor stimulation.
Woodward DF; Spada CS; Hawley SB; Williams LS; Protzman CE; Nieves AL
Eur J Pharmacol; 1993 Jan; 230(3):327-33. PubMed ID: 8440310
[TBL] [Abstract][Full Text] [Related]
13. Effects of a selective DP receptor agonist (BW 245C) and antagonist (BW A868C) on the canine colonic epithelium: an argument for a different DP receptor?
Rangachari PK; Betti PA; Prior ET; Roberts LJ
J Pharmacol Exp Ther; 1995 Nov; 275(2):611-7. PubMed ID: 7473146
[TBL] [Abstract][Full Text] [Related]
14. Prostaglandin DP receptors positively coupled to adenylyl cyclase in embryonic bovine tracheal (EBTr) cells: pharmacological characterization using agonists and antagonists.
Crider JY; Griffin BW; Sharif NA
Br J Pharmacol; 1999 May; 127(1):204-10. PubMed ID: 10369474
[TBL] [Abstract][Full Text] [Related]
15. The cyclo-oxygenase-dependent regulation of rabbit vein contraction: evidence for a prostaglandin E2-mediated relaxation.
Rouaud C; Delaforge M; Anger-Leroy M; Le Filliatre G; Finet M; Hanf R
Br J Pharmacol; 1999 Jan; 126(1):35-44. PubMed ID: 10051118
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological and functional characterization of novel EP and DP receptor agonists: DP1 receptor mediates penile erection in multiple species.
Brugger N; Kim NN; Araldi GL; Traish AM; Palmer SS
J Sex Med; 2008 Feb; 5(2):344-56. PubMed ID: 18047485
[TBL] [Abstract][Full Text] [Related]
17. The role of prostanoid TP- and DP-receptors in the bronchoconstrictor effect of inhaled PGD2 in anaesthetized guinea-pigs: effect of the DP-antagonist BW A868C.
Hamid-Bloomfield S; Payne AN; Petrovic AA; Whittle BJ
Br J Pharmacol; 1990 Aug; 100(4):761-6. PubMed ID: 2119842
[TBL] [Abstract][Full Text] [Related]
18. Differential modulation of human basophil functions through prostaglandin D2 receptors DP and chemoattractant receptor-homologous molecule expressed on Th2 cells/DP2.
Yoshimura-Uchiyama C; Iikura M; Yamaguchi M; Nagase H; Ishii A; Matsushima K; Yamamoto K; Shichijo M; Bacon KB; Hirai K
Clin Exp Allergy; 2004 Aug; 34(8):1283-90. PubMed ID: 15298571
[TBL] [Abstract][Full Text] [Related]
19. Prostanoid receptors involved in the relaxation of human pulmonary vessels.
Walch L; Labat C; Gascard JP; de Montpreville V; Brink C; Norel X
Br J Pharmacol; 1999 Feb; 126(4):859-66. PubMed ID: 10193765
[TBL] [Abstract][Full Text] [Related]
20. GW627368X ((N-{2-[4-(4,9-diethoxy-1-oxo-1,3-dihydro-2H-benzo[f]isoindol-2-yl)phenyl]acetyl} benzene sulphonamide): a novel, potent and selective prostanoid EP4 receptor antagonist.
Wilson RJ; Giblin GM; Roomans S; Rhodes SA; Cartwright KA; Shield VJ; Brown J; Wise A; Chowdhury J; Pritchard S; Coote J; Noel LS; Kenakin T; Burns-Kurtis CL; Morrison V; Gray DW; Giles H
Br J Pharmacol; 2006 Jun; 148(3):326-39. PubMed ID: 16604093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
